Abstract

It has long been recognized that many sesquiterpene lactones possess very prominent anti-infective as well as antitumour potential. The structure-activity relationships underlying these as well as many other aspects of their biological activity have been reviewed extensively. Since 2006, a variety of new data have emerged that warrant an update. The activity of sesquiterpene lactones against “protozoan” parasites has been the topic of studies from various laboratories, and the current chapter will attempt a synopsis of the existing biological data related to inhibitory effects on parasites of the genera Trypanosoma, Leishmania and Plasmodium as causative agents of major tropical diseases. Besides some recent new mechanistic evidence to explain the strong anti-trypanosomal activity of certain sesquiterpene lactones, a main focus will be on quantitative structure-activity relationship studies which have recently led to the discovery of certain furanoheliangolide-type compounds as extremely potent agents against Trypanosoma brucei, the pathogen responsible for human African trypanosomiasis or “sleeping sickness”. Investigations on the long-known antitumoural potential of sesquiterpene lactones have recently received new impetus by the finding that certain compounds of this class possess a hitherto unknown mechanism of action that may make them interesting leads, or even therapeutic agents, against certain types of leukaemia and some other tumours known to be characterized by an excessive activity of the transcription factor c-Myb. This factor plays important roles in cell proliferation and differentiation and has been identified as an interesting drug target. Sesquiterpene lactones were discovered as the first type of low-molecular-weight inhibitors of c-Myb and C/EBP transcriptional activity. Besides extensive QSAR studies on this new activity of sesquiterpene lactones, the chapter will also focus on very recent mechanistic studies into the peculiar mode of action of the most active sesquiterpene lactones on the transcriptional activity of c-Myb and C/EBP.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.